Exact Sciences Corp. (EXAS): Price and Financial Metrics

Exact Sciences Corp. (EXAS): $41.88

0.87 (-2.04%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

EXAS Price/Volume Stats

Current price $41.88 52-week high $100.77
Prev. close $42.75 52-week low $41.20
Day low $41.20 Volume 1,950,226
Day high $42.97 Avg. volume 2,547,129
50-day MA $55.86 Dividend yield N/A
200-day MA $63.65 Market Cap 7.73B

EXAS Stock Price Chart Interactive Chart >


Exact Sciences Corp. (EXAS) Company Bio


Exact Sciences Corp. is a molecular diagnostics company specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer, in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. (Source:Wikipedia)


EXAS Latest News Stream


Event/Time News Detail
Loading, please wait...

EXAS Latest Social Stream


Loading social stream, please wait...

View Full EXAS Social Stream

Latest EXAS News From Around the Web

Below are the latest news stories about EXACT SCIENCES CORP that investors may wish to consider to help them evaluate EXAS as an investment opportunity.

Exact Sciences Corporation (NASDAQ:EXAS) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Exact Sciences is US$107 based on 2 Stage Free Cash Flow to Equity Exact...

Yahoo | December 25, 2023

Exact Sciences' (EXAS) Solid Cologuard Sales, Innovation Aid

Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is offering therapy selection tests for patients with advanced cancer.

Yahoo | December 21, 2023

1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest

If the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right?

Yahoo | December 17, 2023

Ark Invest Stock Portfolio: 16 Biggest Positions

In this article, we discuss the 16 biggest positions in the ARK Invest portfolio. If you want to read about some more stocks in the ARK Invest portfolio, go directly to Ark Invest Stock Portfolio: 5 Biggest Positions. Catherine D. Wood, although relatively new to the industry, stands out as a somewhat controversial hedge fund […]

Yahoo | December 14, 2023

Here's Why You Should Retain Exact Sciences (EXAS) Stock Now

Investors are optimistic about Exact Sciences (EXAS) on strong Cologuard adoption and raised guidance.

Yahoo | December 13, 2023

Read More 'EXAS' Stories Here

EXAS Price Returns

1-mo -21.48%
3-mo -27.43%
6-mo -36.45%
1-year -55.16%
3-year -65.83%
5-year -61.85%
YTD -43.39%
2023 49.42%
2022 -36.39%
2021 -41.26%
2020 43.26%
2019 46.56%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!